Finance

Lists
506820:BOM
Astrazeneca Pharma India Ltd
5 943,85 INR
+0,36%
(+21,25) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 506820...
Open
5 930,00 INR
High
5 985,10 INR
Low
5 860,50 INR
Mkt. cap
149,26 მლრ.
Avg. vol.
525,00
Volume
117,00
Dividend
0,61%
Quarterly dividend
9,00 INR
Ex-dividend date
31 ივლ. 2026
P/E ratio
87,61
52-wk high
9 850,00 INR
52-wk low
5 660,00 INR
EPS
67,85 INR
Shares outstanding
25,00 მლნ.
No. of employees
760
Open
5 930,00 INR
High
5 985,10 INR
Low
5 860,50 INR
Mkt. cap
149,26 მლრ.
Avg. vol.
525,00
Volume
117,00
Dividend
0,61%
Quarterly dividend
9,00 INR
Ex-dividend date
31 ივლ. 2026
P/E ratio
87,61
52-wk high
9 850,00 INR
52-wk low
5 660,00 INR
EPS
67,85 INR
Shares outstanding
25,00 მლნ.
No. of employees
760
News stories
From web sources and news partners
The Fintech Times
The Fintech Times
·
30 წუთის წინ
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Bloomberg.com
Bloomberg.com
·
4 საათის წინ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
About Astrazeneca Pharma India Ltd
CEO-
Employees760
Founded1979
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,59 მლრდ.
6,12 მლრდ.
5,79 მლრდ.
6,83 მლრდ.
Cost of goods sold
3,24 მლრდ.
3,66 მლრდ.
3,98 მლრდ.
4,47 მლრდ.
Cost of revenue
3,24 მლრდ.
3,66 მლრდ.
3,98 მლრდ.
4,47 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
884,60 მლნ.
1,30 მლრდ.
-392,20 მლნ.
1,10 მლრდ.
Operating expense
1,62 მლრდ.
2,04 მლრდ.
1,25 მლრდ.
1,92 მლრდ.
Total operating expenses
4,86 მლრდ.
5,71 მლრდ.
5,23 მლრდ.
6,39 მლრდ.
Operating income
726,10 მლნ.
409,90 მლნ.
556,00 მლნ.
437,10 მლნ.
Other non operating income
61,70 მლნ.
51,30 მლნ.
-175,20 მლნ.
92,30 მლნ.
EBT including unusual items
728,20 მლნ.
465,40 მლნ.
581,40 მლნ.
507,50 მლნ.
EBT excluding unusual items
781,10 მლნ.
450,60 მლნ.
593,50 მლნ.
509,90 მლნ.
Income tax expense
186,00 მლნ.
139,50 მლნ.
132,60 მლნ.
128,20 მლნ.
Effective tax rate
25,54%
29,97%
22,81%
25,26%
Other operating expenses
655,10 მლნ.
694,70 მლნ.
1,49 მლრდ.
741,30 მლნ.
Net income
542,20 მლნ.
325,90 მლნ.
448,80 მლნ.
379,30 მლნ.
Net profit margin
9,70%
5,33%
7,76%
5,56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
232,00 მლნ.
-
Interest expense
-6,70 მლნ.
-10,60 მლნ.
-20,40 მლნ.
-19,50 მლნ.
Net interest expenses
-6,70 მლნ.
-10,60 მლნ.
211,60 მლნ.
-19,50 მლნ.
Depreciation and amortization charges
25,70 მლნ.
38,40 მლნ.
56,00 მლნ.
52,30 მლნ.
EBITDA
821,80 მლნ.
493,98 მლნ.
598,30 მლნ.
479,40 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები